We only have this paper's title and publication details.
Read it at the sourceCaptured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We ultimately think it's a great asset. It forms the foundation not only for knowing how you are doing, but also for understanding whether or not there are racial or gender disparities in outcomes. It allows hospitals to figure out whether or not they need to really focus on a quality-improvement program to reduce complications of angioplasty, etc. There's just so much value in it to the hospitals.”
“More than 40% of clinical registry data would be extractable using FHIR; it's not 100% yet, but we are moving in the right direction.”
“The NCDR has really taken a leadership position in saying that we as a profession need to understand what we're doing to whom and what are the results. There are numerous examples of how doing this has improved patient outcomes and decreased costs, which is bringing value to healthcare.”
No takes yet. Share an insight, caveat, or question.
Brindis et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: